Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, Srivastava RM, Ostrovnaya I, Prasad M, Zuur CL, Riaz N, Pfister DG, Klebanoff CA, Chan TA, Ho AL, Morris LGT. Vos JL, et al. Among authors: kriplani a. Nat Med. 2023 Dec;29(12):3077-3089. doi: 10.1038/s41591-023-02518-x. Epub 2023 Aug 24. Nat Med. 2023. PMID: 37620627 Clinical Trial.
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer.
Kang JJ, Yu Y, Chen L, Zakeri K, Gelblum DY, McBride SM, Riaz N, Tsai CJ, Kriplani A, Hung TKW, Fetten JV, Dunn LA, Ho AL, Boyle JO, Ganly IS, Singh B, Sherman EJ, Pfister DG, Wong RJ, Lee NY. Kang JJ, et al. Among authors: kriplani a. CA Cancer J Clin. 2023 Mar;73(2):164-197. doi: 10.3322/caac.21758. Epub 2022 Oct 28. CA Cancer J Clin. 2023. PMID: 36305841 Free PMC article. Review.
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I, Yoon J, Mohamed N, Zakeri K, Press RH, Chen L, Gelblum DY, McBride SM, Tsai CJ, Riaz N, Yu Y, Cohen MA, Dunn LA, Ho AL, Wong RJ, Michel LS, Boyle JO, Singh B, Kriplani A, Ganly I, Sherman EJ, Pfister DG, Fetten J, Lee NY. Youssef I, et al. Among authors: kriplani a. JAMA Netw Open. 2022 Nov 1;5(11):e2241538. doi: 10.1001/jamanetworkopen.2022.41538. JAMA Netw Open. 2022. PMID: 36367724 Free PMC article.
Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations.
Lipitz-Snyderman A, Chimonas S, Mailankody S, Kim M, Silva N, Kriplani A, Saltz LB, Sihag S, Tan CR, Widmar M, Zauderer M, Weingart S, Perchick W, Roman BR. Lipitz-Snyderman A, et al. Among authors: kriplani a. Cancer Med. 2023 Apr;12(7):8063-8072. doi: 10.1002/cam4.5598. Epub 2023 Feb 3. Cancer Med. 2023. PMID: 36737878 Free PMC article.
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
Ku GY, Kriplani A, Janjigian YY, Kelsen DP, Rusch VW, Bains M, Chou J, Capanu M, Wu AJ, Goodman KA, Ilson DH. Ku GY, et al. Among authors: kriplani a. Cancer. 2016 Jul 1;122(13):2083-90. doi: 10.1002/cncr.30028. Epub 2016 May 6. Cancer. 2016. PMID: 27152857 Free PMC article.
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
Francis JH, Harding JJ, Schram AM, Canestraro J, Haggag-Lindgren D, Heinemann M, Kriplani A, Jhaveri K, Voss MH, Bajorin D, Abou-Alfa GK, Iyer G, Drilon A, Rosenberg J, Abramson DH. Francis JH, et al. Among authors: kriplani a. JAMA Ophthalmol. 2021 Oct 1;139(10):1126-1130. doi: 10.1001/jamaophthalmol.2021.3331. JAMA Ophthalmol. 2021. PMID: 34473206 Free PMC article.
Safety of opioid prescribing among older cancer survivors.
Salz T, Mishra A, Gennarelli RL, Lipitz-Snyderman A, Moryl N, Tringale KR, Boudreau DM, Kriplani A, Jinna S, Korenstein D. Salz T, et al. Among authors: kriplani a. Cancer. 2022 Feb 1;128(3):570-578. doi: 10.1002/cncr.33963. Epub 2021 Oct 11. Cancer. 2022. PMID: 34633662 Free PMC article.
Trends in chronic opioid therapy among survivors of head and neck cancer.
Kriplani A, Lavery JA, Mishra A, Korenstein D, Lipitz-Snyderman AN, Boudreau DM, Moryl N, Gillespie EF, Salz T. Kriplani A, et al. Head Neck. 2021 Jan;43(1):223-228. doi: 10.1002/hed.26478. Epub 2020 Sep 22. Head Neck. 2021. PMID: 32964530 Free PMC article.
The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors.
Salz T, Ostroff JS, Nightingale CL, Atkinson TM, Davidson EC, Jinna SR, Kriplani A, Lesser GJ, Lynch KA, Mayer DK, Oeffinger KC, Patil S, Salner AL, Weaver KE. Salz T, et al. Among authors: kriplani a. Contemp Clin Trials. 2021 Aug;107:106448. doi: 10.1016/j.cct.2021.106448. Epub 2021 May 21. Contemp Clin Trials. 2021. PMID: 34023515 Free PMC article.
285 results